Patent details

Basic Information

Publication number:

EP1740202

PCT Application Number:

PCT/CA/2005/000184

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP057064875

PCT Publication Number:

WO/2005/077404

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF LUTEINIZING HORMONE (LH) AND CHORIONIC GONADOTROPIN (HCG) FOR PROLIFERATION OF NEURAL STEM CELLS AND NEUROGENESIS

French Title of Invention:

UTILISATION DE L'HORMONE DE LUTEINISATION (LH) ET DE LA GONADOTROPINE CHORIONIQUE (HCG) POUR LA PROLIFERATION DE CELLULES SOUCHES NEURONALES ET LA NEUROGENESE

German Title of Invention:

VERWENDUNG DES LUTEINISIERENDEN HORMONS (LH) UND VON CHORIONGONADOTROPHIN (HCG) FÜR DIE PROLIFERATION VON NEURALEN STAMMZELLEN UND NEUROGENESE

SPC Number:

Dates

Filing date:

14/02/2005

Grant date:

09/05/2012

EP Publication Date:

09/05/2012

PCT Publication Date:

25/08/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/01/2007

EP B1 Publication Date:

09/05/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/02/2013

Expiration date:

14/02/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/02/2005

 

 

Name:

Stem Cell Therapeutics Corp.

Address:

Bow Valley Square III 255 5th Avenue SW Suite 500, Calgary, AB T2P 3G6, Canada (CA)

Inventor

1

Name:

ANDERSEN Linda

Address:

Canada (CA)

2

Name:

GREGG Christopher

Address:

Canada (CA)

3

Name:

ENWERE Emeka

Address:

Canada (CA)

4

Name:

WEISS Samuel

Address:

Canada (CA)

Priority

Priority Number:

544915 P

Priority Date:

13/02/2004

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/24;

Filing date	Document type	Number of pages